Lewis Tanya

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2023-06-15	2023-06-13	Replimune Group Inc (REPL)	PS Planned sale	817 -0.6% 23.45 USD 19,159	817 -0.6%	23.45	USD 19,159
2023-06-15	2023-06-13	Replimune Group Inc (REPL)	PS Planned sale	12,043 -8.1% 24.10 USD 290,236	12,043 -8.1%	24.10	USD 290,236
2023-05-18	2023-05-16	Replimune Group Inc (REPL)	S Sale	12,207 -7.6% 18.05 USD 220,336	12,207 -7.6%	18.05	USD 220,336
2022-05-18	2022-05-16	Replimune Group Inc (REPL)	S Sale	5,473 -4.3% 14.59 USD 79,851	5,473 -4.3%	14.59	USD 79,851
2021-02-17	2021-02-11	Karyopharm Therapeutics Inc (KPTI)	S Sale	2,046 -33.1% 15.52 USD 31,752	2,046 -33.1%	15.52	USD 31,752
2020-11-04	2020-10-30	Karyopharm Therapeutics Inc (KPTI)	S Sale	226 -29.5% 15.58 USD 3,521	226 -29.5%	15.58	USD 3,521